Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial

Li, DD; Tao, ZH; Wang, BY; Wang, LP; Cao, J; Hu, XC; Zhang, J

Hu, XC; Zhang, J (通讯作者)，Fudan Univ, Dept Med Oncol, Shanghai, Peoples R China.;Hu, XC; Zhang, J (通讯作者)，Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China.;Hu, XC; Zhang, J (通讯作者)，Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai, Peoples R China.

NPJ BREAST CANCER, 2022; 8 (1):

Abstract

While therapies such as chemotherapy combined with immunotherapy, sacituzumab govitecan, and PARP inhibitors are available for metastatic TNBC, on dis......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索